2023 Q2 Form 10-Q Financial Statement

#000088414423000037 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $30.42M $33.06M
YoY Change 49.85% 35.88%
Cost Of Revenue $8.402M $8.664M
YoY Change 4.52% -2.31%
Gross Profit $22.02M $24.40M
YoY Change 79.58% 57.79%
Gross Profit Margin 72.38% 73.8%
Selling, General & Admin $18.85M $17.16M
YoY Change 41.9% 38.56%
% of Gross Profit 85.62% 70.31%
Research & Development $1.325M $1.979M
YoY Change -9.99% 8.68%
% of Gross Profit 6.02% 8.11%
Depreciation & Amortization $4.886M $4.789M
YoY Change 6.01% 0.74%
% of Gross Profit 22.19% 19.63%
Operating Expenses $23.47M $22.44M
YoY Change 29.6% 27.23%
Operating Profit -$1.452M $1.963M
YoY Change -75.17% -190.42%
Interest Expense -$1.593M -$1.944M
YoY Change 46.82% 138.24%
% of Operating Profit -99.03%
Other Income/Expense, Net -$93.00K $83.00K
YoY Change -109.62%
Pretax Income -$3.138M $102.0K
YoY Change -45.77% -103.41%
Income Tax $627.0K -$237.0K
% Of Pretax Income -232.35%
Net Earnings -$3.765M $339.0K
YoY Change -35.75% -111.24%
Net Earnings / Revenue -12.38% 1.03%
Basic Earnings Per Share -$0.18 $0.02
Diluted Earnings Per Share -$0.18 $0.02
COMMON SHARES
Basic Shares Outstanding 20.62M shares 20.27M shares
Diluted Shares Outstanding 20.65M shares 21.04M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.38M $28.23M
YoY Change 44.22% 46.4%
Cash & Equivalents $21.61M $21.44M
Short-Term Investments $9.762M $6.789M
Other Short-Term Assets $190.5M $228.5M
YoY Change -2.21% -8.33%
Inventory $134.0K $218.0K
Prepaid Expenses $3.960M $5.075M
Receivables $16.63M $14.76M
Other Receivables $0.00 $0.00
Total Short-Term Assets $228.9M $265.0M
YoY Change 6.25% -1.23%
LONG-TERM ASSETS
Property, Plant & Equipment $12.59M $11.94M
YoY Change 38.7% 37.86%
Goodwill $86.01M $86.01M
YoY Change 0.0% 0.0%
Intangibles $60.64M $63.02M
YoY Change -17.68% -18.37%
Long-Term Investments
YoY Change
Other Assets $7.033M $6.376M
YoY Change 53.22% 44.71%
Total Long-Term Assets $172.2M $173.9M
YoY Change -3.93% -4.25%
TOTAL ASSETS
Total Short-Term Assets $228.9M $265.0M
Total Long-Term Assets $172.2M $173.9M
Total Assets $401.0M $438.8M
YoY Change 1.63% -2.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.365M $1.744M
YoY Change 58.35% 7.72%
Accrued Expenses $12.89M $11.08M
YoY Change 37.64% 56.71%
Deferred Revenue $3.293M $4.182M
YoY Change 61.58% 157.2%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.557M $5.418M
YoY Change 236.77% 205.58%
Total Short-Term Liabilities $215.3M $250.8M
YoY Change 7.13% -0.66%
LONG-TERM LIABILITIES
Long-Term Debt $30.23M $30.48M
YoY Change -10.86% -10.3%
Other Long-Term Liabilities $154.0K $132.0K
YoY Change 50.98% 112.9%
Total Long-Term Liabilities $38.93M $38.87M
YoY Change -11.76% -8.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $215.3M $250.8M
Total Long-Term Liabilities $38.93M $38.87M
Total Liabilities $254.2M $289.6M
YoY Change 3.73% -1.81%
SHAREHOLDERS EQUITY
Retained Earnings -$284.7M -$280.9M
YoY Change 3.27% 4.12%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.017M $5.017M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $146.8M $149.2M
YoY Change
Total Liabilities & Shareholders Equity $401.0M $438.8M
YoY Change 1.63% -2.45%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$3.765M $339.0K
YoY Change -35.75% -111.24%
Depreciation, Depletion And Amortization $4.886M $4.789M
YoY Change 6.01% 0.74%
Cash From Operating Activities $1.508M $4.588M
YoY Change -69.54% 81.34%
INVESTING ACTIVITIES
Capital Expenditures $2.437M $726.0K
YoY Change -269.94% 1220.0%
Acquisitions
YoY Change
Other Investing Activities -$8.182M -$4.763M
YoY Change -39.02% 18.99%
Cash From Investing Activities -$10.62M -$6.647M
YoY Change -28.5% -1.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -36.73M $21.13M
YoY Change -31.75% -0.79%
NET CHANGE
Cash From Operating Activities 1.508M $4.588M
Cash From Investing Activities -10.62M -$6.647M
Cash From Financing Activities -36.73M $21.13M
Net Change In Cash -45.84M $19.07M
YoY Change -28.06% 11.47%
FREE CASH FLOW
Cash From Operating Activities $1.508M $4.588M
Capital Expenditures $2.437M $726.0K
Free Cash Flow -$929.0K $3.862M
YoY Change -114.55% 56.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000884144
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-34522
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ASURE SOFTWARE, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2415696
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
405 Colorado Street, Suite 1800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78701
CY2023Q1 dei City Area Code
CityAreaCode
512
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
437-2700
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20623010 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21438000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17010000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4027000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3248000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14762000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12123000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
218000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
251000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5075000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10304000 usd
CY2023Q1 asur Assets Before Funds Held For Clients Current
AssetsBeforeFundsHeldForClientsCurrent
41493000 usd
CY2022Q4 asur Assets Before Funds Held For Clients Current
AssetsBeforeFundsHeldForClientsCurrent
39688000 usd
CY2023Q1 us-gaap Funds Held For Clients
FundsHeldForClients
223465000 usd
CY2022Q4 us-gaap Funds Held For Clients
FundsHeldForClients
203588000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
264958000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
243276000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11944000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11439000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
86011000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
86011000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
63024000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
66594000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6531000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7065000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6376000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5523000 usd
CY2023Q1 us-gaap Assets
Assets
438844000 usd
CY2022Q4 us-gaap Assets
Assets
419908000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
5418000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4106000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1744000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2194000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4391000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5791000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1671000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1860000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5013000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3728000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2886000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2955000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4182000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8461000 usd
CY2023Q1 asur Liablities Before Client Fund Obligations Current
LiablitiesBeforeClientFundObligationsCurrent
25305000 usd
CY2022Q4 asur Liablities Before Client Fund Obligations Current
LiablitiesBeforeClientFundObligationsCurrent
29095000 usd
CY2023Q1 asur Client Fund Obligations Current
ClientFundObligationsCurrent
225462000 usd
CY2022Q4 asur Client Fund Obligations Current
ClientFundObligationsCurrent
206088000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
250767000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
235183000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
728000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
788000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1430000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1503000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
30478000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
30795000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6098000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6459000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
132000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
114000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38866000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
39659000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
289633000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
274842000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
44000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
44000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21003000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20628000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20619000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20244000 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
210000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
206000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
384000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
384000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5017000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5017000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
436907000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
433586000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-280887000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-281226000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2002000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2483000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
149211000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145066000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
438844000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
419908000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33064000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24333000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8664000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8869000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
24400000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
15464000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7200000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4897000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9956000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7485000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1979000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1821000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3302000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3432000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
22437000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
17635000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1963000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2171000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1944000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-820000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
83000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
102000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2987000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-237000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
339000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3017000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
481000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1063000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
820000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4080000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20347000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20041000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21041000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20041000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
145066000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1988000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1337000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
339000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
481000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
149211000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
158240000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
729000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3017000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1063000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
154890000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
339000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3017000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4789000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4754000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
307000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
430000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
169000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
164000 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
982000 usd
CY2022Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
0 usd
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
14000 usd
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-118000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
652000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-48000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-73000 usd
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
22000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
453000 usd
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
203000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1337000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
729000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-160000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-69000 usd
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
3290000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1252000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4850000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2756000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-450000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1072000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-123000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-345000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-219000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-476000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4339000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2137000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4588000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2530000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1970000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
726000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1158000 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
691000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
10189000 usd
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4504000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5426000 usd
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
501000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6647000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6719000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
232000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1988000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 asur Proceeds Payments From Client Fund Obligations
ProceedsPaymentsFromClientFundObligations
19372000 usd
CY2022Q1 asur Proceeds Payments From Client Fund Obligations
ProceedsPaymentsFromClientFundObligations
21296000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21128000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21296000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19069000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17107000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
164042000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198743000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183111000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215850000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21438000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12054000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
161673000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
203796000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183111000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215850000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1038000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
684000 usd
CY2023Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
82000 usd
CY2022Q1 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
14000 usd
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2022Q1 us-gaap Notes Issued1
NotesIssued1
411000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates are subjective in nature and involve judgments. The more significant estimates made by management include the valuation allowance for the gross deferred tax assets, the determination of the fair value of its long-lived assets, and the fair value of assets acquired and liabilities assumed during acquisitions. We base our estimates on historical experience and on various other assumptions management believes reasonable under the given circumstances. These estimates could be materially different under different conditions and assumptions.</span></div>
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1970000 usd
CY2022Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
31000 usd
CY2022Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
411000 usd
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
4080000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2299000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents Amortized Cost
FundsHeldForClientsRestrictedCashEquivalentsAmortizedCost
6297000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents Gross Unrealized Gains
FundsHeldForClientsRestrictedCashEquivalentsGrossUnrealizedGains
0 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents Gross Unrealized Losses
FundsHeldForClientsRestrictedCashEquivalentsGrossUnrealizedLosses
11000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents
FundsHeldForClientsRestrictedCashEquivalents
6286000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities Amortized Cost
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecuritiesAmortizedCost
70084000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities Gross Unrealized Gains
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecuritiesGrossUnrealizedGains
65000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash And Debt Securities Gross Unrealized Losses
FundsHeldForClientsRestrictedCashAndDebtSecuritiesGrossUnrealizedLosses
2071000 usd
CY2023Q1 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecurities
68078000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents Amortized Cost
FundsHeldForClientsRestrictedCashEquivalentsAmortizedCost
2829000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents Gross Unrealized Gains
FundsHeldForClientsRestrictedCashEquivalentsGrossUnrealizedGains
0 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents Gross Unrealized Losses
FundsHeldForClientsRestrictedCashEquivalentsGrossUnrealizedLosses
0 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents
FundsHeldForClientsRestrictedCashEquivalents
2829000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities Amortized Cost
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecuritiesAmortizedCost
61860000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities Gross Unrealized Gains
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecuritiesGrossUnrealizedGains
5000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash And Debt Securities Gross Unrealized Losses
FundsHeldForClientsRestrictedCashAndDebtSecuritiesGrossUnrealizedLosses
2480000 usd
CY2022Q4 asur Funds Held For Clients Restricted Cash Equivalents And Debt Securities
FundsHeldForClientsRestrictedCashEquivalentsAndDebtSecurities
59385000 usd
CY2023Q1 asur Number Of Securities In Unrealized Gain Position
NumberOfSecuritiesInUnrealizedGainPosition
23 security
CY2022Q4 asur Number Of Securities In Unrealized Gain Position
NumberOfSecuritiesInUnrealizedGainPosition
3 security
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
114 security
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
124 security
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2071000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
161673000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
147032000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
6789000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
9174000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
55003000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
47382000 usd
CY2023Q1 us-gaap Funds Held For Clients
FundsHeldForClients
223465000 usd
CY2022Q4 us-gaap Funds Held For Clients
FundsHeldForClients
203588000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
6789000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
55003000 usd
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
61792000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
86011000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 usd
CY2023Q1 us-gaap Goodwill
Goodwill
86011000 usd
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
132228000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y4M24D
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
132228000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
69204000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63024000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P8Y4M24D
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
132228000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
65634000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66594000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
straight-line method
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
straight-line method
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3302000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3432000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
268000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
296000 usd
CY2023Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
10030000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13338000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12554000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9442000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7267000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5816000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
4577000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
63024000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
38379000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
37554000 usd
CY2023Q1 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
625000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
5418000 usd
CY2023Q1 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
1858000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30478000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
38379000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2483000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
35896000 usd
CY2022Q4 us-gaap Deferred Finance Costs Current Gross
DeferredFinanceCostsCurrentGross
668000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4106000 usd
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Gross
DeferredFinanceCostsNoncurrentGross
1985000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30795000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
37554000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2653000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
34901000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4543000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6367000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
24494000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2975000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
38379000 usd
CY2023Q1 us-gaap Repayments Of Subordinated Debt
RepaymentsOfSubordinatedDebt
232000 usd
CY2023Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
4027000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14762000 usd
CY2022Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
3248000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12123000 usd
CY2023Q1 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
7525000 usd
CY2022Q4 us-gaap Accrued Sales Commission Current And Noncurrent
AccruedSalesCommissionCurrentAndNoncurrent
6660000 usd
CY2023Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
496000 usd
CY2022Q1 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
345000 usd
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
5613000 usd
CY2022Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3058000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21295000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.92
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
531000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
557000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
5000 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
11000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
526000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
546000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
494000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
476000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1759000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2154000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1765000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1313000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1121000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1075000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
567000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9754000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1985000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
7769000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1337000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
729000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
277000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
98000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
43000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
773000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
339000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3017000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20347000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20041000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
339000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-3017000 usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21041000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20041000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15

Files In Submission

Name View Source Status
0000884144-23-000037-index-headers.html Edgar Link pending
0000884144-23-000037-index.html Edgar Link pending
0000884144-23-000037.txt Edgar Link pending
0000884144-23-000037-xbrl.zip Edgar Link pending
a20230331exhibit311.htm Edgar Link pending
a20230331exhibit312.htm Edgar Link pending
a20230331exhibit321.htm Edgar Link pending
a20230331exhibit322.htm Edgar Link pending
asur-20230331.htm Edgar Link pending
asur-20230331.xsd Edgar Link pending
asur-20230331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
asur-20230331_def.xml Edgar Link unprocessable
asur-20230331_lab.xml Edgar Link unprocessable
asur-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
asur-20230331_pre.xml Edgar Link unprocessable
asur-20230331_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending